JP2009511600A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009511600A5 JP2009511600A5 JP2008535735A JP2008535735A JP2009511600A5 JP 2009511600 A5 JP2009511600 A5 JP 2009511600A5 JP 2008535735 A JP2008535735 A JP 2008535735A JP 2008535735 A JP2008535735 A JP 2008535735A JP 2009511600 A5 JP2009511600 A5 JP 2009511600A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- particle
- compound according
- amino acid
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108090000765 processed proteins & peptides Proteins 0.000 claims 37
- 239000002245 particle Substances 0.000 claims 20
- 150000001875 compounds Chemical class 0.000 claims 19
- 108091032973 (ribonucleotides)n+m Proteins 0.000 claims 11
- 102000040650 (ribonucleotides)n+m Human genes 0.000 claims 11
- 125000003275 alpha amino acid group Chemical group 0.000 claims 8
- 150000001413 amino acids Chemical class 0.000 claims 2
- 244000089409 Erythrina poeppigiana Species 0.000 claims 1
- 235000009776 Rathbunia alamosensis Nutrition 0.000 claims 1
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US72721605P | 2005-10-14 | 2005-10-14 | |
| US60/727,216 | 2005-10-14 | ||
| US73366405P | 2005-11-04 | 2005-11-04 | |
| US60/733,664 | 2005-11-04 | ||
| US82587806P | 2006-09-15 | 2006-09-15 | |
| US60/825,878 | 2006-09-15 | ||
| PCT/US2006/040174 WO2007047482A2 (en) | 2005-10-14 | 2006-10-13 | Compounds and methods for peptide ribonucleic acid condensate particles for rna therapeutics |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014002769A Division JP2014110796A (ja) | 2005-10-14 | 2014-01-09 | Ｒｎａ治療用ペプチドリボ核酸縮合体粒子のための化合物及び方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2009511600A JP2009511600A (ja) | 2009-03-19 |
| JP2009511600A5 true JP2009511600A5 (enExample) | 2009-12-03 |
| JP5536334B2 JP5536334B2 (ja) | 2014-07-02 |
Family
ID=37963128
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008535735A Expired - Fee Related JP5536334B2 (ja) | 2005-10-14 | 2006-10-13 | Ｒｎａ治療用ペプチドリボ核酸縮合体粒子のための化合物及び方法 |
| JP2014002769A Pending JP2014110796A (ja) | 2005-10-14 | 2014-01-09 | Ｒｎａ治療用ペプチドリボ核酸縮合体粒子のための化合物及び方法 |
| JP2015219682A Pending JP2016073290A (ja) | 2005-10-14 | 2015-11-09 | Ｒｎａ治療用ペプチドリボ核酸縮合体粒子のための化合物及び方法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014002769A Pending JP2014110796A (ja) | 2005-10-14 | 2014-01-09 | Ｒｎａ治療用ペプチドリボ核酸縮合体粒子のための化合物及び方法 |
| JP2015219682A Pending JP2016073290A (ja) | 2005-10-14 | 2015-11-09 | Ｒｎａ治療用ペプチドリボ核酸縮合体粒子のための化合物及び方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US20100129460A1 (enExample) |
| EP (1) | EP1934360A2 (enExample) |
| JP (3) | JP5536334B2 (enExample) |
| KR (1) | KR20080061397A (enExample) |
| CN (1) | CN101331231B (enExample) |
| AU (1) | AU2006304291A1 (enExample) |
| CA (1) | CA2625473A1 (enExample) |
| MX (1) | MX2008004899A (enExample) |
| WO (1) | WO2007047482A2 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW200932274A (en) | 2007-12-18 | 2009-08-01 | Alcon Res Ltd | Interfering RNA delivery system and uses thereof |
| WO2010021718A1 (en) * | 2008-08-19 | 2010-02-25 | Nektar Therapeutics | Complexes of small-interfering nucleic acids |
| WO2010059829A2 (en) * | 2008-11-19 | 2010-05-27 | Mdrna, Inc. | Compositions and methods for triggered release rna therapeutics |
| US9579394B2 (en) * | 2011-08-08 | 2017-02-28 | Universitaet Regensburg | Polyanion nanocomplexes for therapeutic applications |
| EP2623978A1 (en) | 2012-02-03 | 2013-08-07 | Charité - Universitätsmedizin Berlin | CD8+ T-cell subsets as markers for prediction of delayed fracture healing |
| WO2014183017A1 (en) * | 2013-05-09 | 2014-11-13 | KIPPERMAN, Richard, M. as Chapter 7 Bankruptcy Trustee for TRAVERSA THERAPEUTICS, INC. | Improved delivery of rna interfering agents |
| BR112018006358A2 (pt) * | 2015-10-05 | 2018-10-09 | Devgen Nv | métodos de conservação da atividade biológica de ácidos ribonucleicos. |
| JP7577337B2 (ja) * | 2019-07-24 | 2024-11-05 | 国立大学法人東北大学 | キメラ分子、医薬組成物、標的核酸の切断方法、及び、標的核酸切断用又は診断用キット |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9218164D0 (en) * | 1992-08-26 | 1992-10-14 | Applied Research Systems | Virus and substances related thereto |
| US5679559A (en) * | 1996-07-03 | 1997-10-21 | University Of Utah Research Foundation | Cationic polymer and lipoprotein-containing system for gene delivery |
| EP1242052A4 (en) * | 1999-12-29 | 2003-07-02 | A James Mixson | HISTIDIN COPOLYMER AND METHODS OF USE THEREOF |
| JP2003522203A (ja) * | 2000-02-07 | 2003-07-22 | トランジェーヌ、ソシエテ、アノニム | 天然に存在しない核酸組成物、核酸を細胞中にトランスフェクションするのに有用な処方物の調製のためのそれらの使用、および応用 |
| AU2001269385A1 (en) * | 2000-06-14 | 2001-12-24 | Transgene S.A. | Combination product intended for carrying out a cytotoxic treatment, in particular an antitumour treatment, in a mammal |
| AU2001294872A1 (en) * | 2000-09-28 | 2002-04-08 | Cellomics, Inc. | Methods and reagents for live-cell gene expression quantification |
| JP2004035409A (ja) * | 2002-05-15 | 2004-02-05 | Geneshuttle Biopharm Inc | ベクターとしての使用のための新規融合タンパク質 |
| US20040019008A1 (en) * | 2002-05-28 | 2004-01-29 | Lewis David L. | Compositions and processes using siRNA, amphipathic compounds and polycations |
| EP1507874A4 (en) * | 2002-05-28 | 2006-06-28 | Mirus Bio Corp | COMPOSITIONS AND METHODS FOR INHIBITING GENE EXPRESSION USING POLYNUCLEOTIDES |
| FR2841137B1 (fr) * | 2002-06-20 | 2004-08-13 | Bioalliance Pharma | Systeme de vectorisation comprenant des nanoparticules de taille homogene d'au moins un polymere et d'au moins un polysaccharide charge positivement |
| WO2004028471A2 (en) * | 2002-09-28 | 2004-04-08 | Massachusetts Institute Of Technology | Influenza therapeutic |
| US8324365B2 (en) * | 2003-04-03 | 2012-12-04 | Korea Advanced Institute Of Science And Technology | Conjugate for gene transfer comprising oligonucleotide and hydrophilic polymer, polyelectrolyte complex micelles formed from the conjugate, and methods for preparation thereof |
| US20050136437A1 (en) * | 2003-08-25 | 2005-06-23 | Nastech Pharmaceutical Company Inc. | Nanoparticles for delivery of nucleic acids and stable double-stranded RNA |
| CA2543257C (en) * | 2003-10-24 | 2013-12-31 | Gencia Corporation | Methods and compositions for delivering polynucleotides |
| AU2005206566A1 (en) * | 2004-01-22 | 2005-08-04 | University Of Massachusetts | Modulation of HSV infection |
| CN101103111A (zh) * | 2004-11-05 | 2008-01-09 | 因特拉迪格姆公司 | 用于治疗呼吸道病毒感染的组合物及其用途 |
| WO2006060182A2 (en) * | 2004-11-17 | 2006-06-08 | University Of Maryland, Baltimore | HIGHLY BRANCHED HK PEPTIDES AS EFFECTIVE CARRIERS OF siRNA |
| CN101277704A (zh) * | 2005-04-12 | 2008-10-01 | 因特拉迪格姆公司 | 用于治疗癌症及其它新血管生成疾病的RNAi治疗剂的组合物和方法 |
| US9505867B2 (en) * | 2005-05-31 | 2016-11-29 | Ecole Polytechmique Fédérale De Lausanne | Triblock copolymers for cytoplasmic delivery of gene-based drugs |
| US20070213257A1 (en) * | 2005-08-12 | 2007-09-13 | Nastech Pharmaceutical Company Inc. | Compositions and methods for complexes of nucleic acids and peptides |
-
2006
- 2006-10-13 US US12/445,575 patent/US20100129460A1/en not_active Abandoned
- 2006-10-13 WO PCT/US2006/040174 patent/WO2007047482A2/en not_active Ceased
- 2006-10-13 CA CA002625473A patent/CA2625473A1/en not_active Abandoned
- 2006-10-13 MX MX2008004899A patent/MX2008004899A/es active IP Right Grant
- 2006-10-13 CN CN2006800468655A patent/CN101331231B/zh not_active Expired - Fee Related
- 2006-10-13 AU AU2006304291A patent/AU2006304291A1/en not_active Abandoned
- 2006-10-13 JP JP2008535735A patent/JP5536334B2/ja not_active Expired - Fee Related
- 2006-10-13 KR KR1020087011424A patent/KR20080061397A/ko not_active Withdrawn
- 2006-10-13 EP EP06836308A patent/EP1934360A2/en not_active Withdrawn
-
2012
- 2012-05-18 US US13/475,892 patent/US20130072424A1/en not_active Abandoned
-
2014
- 2014-01-09 JP JP2014002769A patent/JP2014110796A/ja active Pending
-
2015
- 2015-11-09 JP JP2015219682A patent/JP2016073290A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Zinchenko et al. | Compaction of single-chain DNA by histone-inspired nanoparticles | |
| JP2018538006A5 (enExample) | ||
| WO2005118644A3 (en) | Binding molecules capable of neutralizing rabies virus and uses thereof | |
| JP2009514877A5 (enExample) | ||
| WO2004029212A3 (en) | In vivo gene silencing by chemically modified and stable sirna | |
| JP2011529686A5 (enExample) | ||
| JP2009511600A5 (enExample) | ||
| JP2011530537A5 (enExample) | ||
| HRP20160209T1 (hr) | Antigenski vežuća molekula koja se može višekratno vezati na dva ili više antigena | |
| WO2003089906A3 (en) | Functionalized nanoparticles and methods of use | |
| JP2017517900A5 (enExample) | ||
| JP2009527226A5 (enExample) | ||
| JP2009531694A5 (enExample) | ||
| CN112823207B (zh) | 磁性纳米颗粒上的二氧化硅包封的dna | |
| JP2007536906A5 (enExample) | ||
| WO2007093409A3 (en) | Mcp-i binding nucleic acids | |
| WO2005054438A3 (en) | Nucleic acid molecules containing recombination sites and methods of using the same | |
| JP2023171909A5 (enExample) | ||
| WO2002101088A3 (en) | In vitro capture of nucleic acids via modified oligonucleotides and magnetic beads | |
| JP2011525914A5 (enExample) | ||
| JP2006503088A5 (enExample) | ||
| WO2007047482A3 (en) | Compounds and methods for peptide ribonucleic acid condensate particles for rna therapeutics | |
| JP2009532334A5 (enExample) | ||
| Wang et al. | Thermally responsive silicon nanowire arrays for native/denatured-protein separation | |
| Estephan et al. | Phages recognizing the indium nitride semiconductor surface via their peptides |